Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Anterior cruciate ligament substituting knee implants

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Publication Date:
    June 02, 2020
  • معلومة اضافية
    • Patent Number:
      10667,919
    • Appl. No:
      15/839080
    • Application Filed:
      December 12, 2017
    • نبذة مختصرة :
      The present disclosure provides knee prostheses that replicate at least a portion of the function of an individual patient's anterior cruciate ligament (ACL). An exemplary knee prosthesis includes a femoral component configured to be implanted on the distal end of the patient's femur and a tibial component configured to be implanted on the proximal end of the patient's tibia. In extension, the femoral component and the tibial component may cooperate to limit anterior movement of the tibial component relative to the femoral component. In flexion, the femoral component may be free to rotate relative to the tibial component.
    • Inventors:
      Zimmer, Inc. (Warsaw, IN, US)
    • Assignees:
      Zimmer, Inc. (Warsaw, IN, US)
    • Claim:
      1. A knee prosthesis that articulates between an extended position and a flexed position, the knee prosthesis including an axis that is medially offset from a center of the knee prosthesis, the knee prosthesis comprising: a femoral component including: a medial condyle; a lateral condyle; and a patella-femoral flange positioned between the medial and lateral condyles, the patella-femoral flange having a distal-most end; wherein the medial condyle, the patella-femoral flange and the lateral condyle define an intercondylar compartment; and a tibial component including: a medial surface sized to receive the medial condyle of the femoral component; a lateral surface sized to receive the lateral condyle of the femoral component; and a projection extending from between the medial and lateral surfaces into the intercondylar compartment, the projection continuously decreasing in height and width from an anterior end to a posterior end; wherein the femoral and tibial components are, via engagement of the projection with portions of the medial condyle, lateral condyle and patella-femoral flange that define the intercondylar compartment, more constrained against the following movements when the knee prosthesis is in the extended position than when the knee prosthesis is in the flexed position: a rotational movement of the femoral component relative to the tibial component about the axis; an anterior movement of the tibial component relative to the femoral component; and a lateral movement of the femoral component relative to the tibial component; whereby the knee prosthesis resists the rotational movement, the anterior movement, and the lateral movement to a first greater extent when the knee prosthesis is in the extended position than when the knee prosthesis is in the flexed position.
    • Claim:
      2. The knee prosthesis of claim 1 , wherein the patella-femoral flange includes a barrier defined by a posterior wall of the distal-most end of the patella-femoral flange, an anterior wall of the projection of the tibial component engaging the barrier of the femoral component when the knee prosthesis is in the extended position to limit the anterior movement.
    • Claim:
      3. The knee prosthesis of claim 2 , wherein the projection gradually decreases in size in a posterior direction, the projection having less contact with the medial and lateral condyles of the femoral component when the knee prosthesis is in the flexed position than when the knee prosthesis is in the extended position, whereby the knee prosthesis is capable of undergoing the rotational movement to a second greater extent when the knee prosthesis is in the flexed position than when the knee prosthesis is in the extended position.
    • Claim:
      4. The knee prosthesis of claim 2 , wherein the projection comprises: a distal portion connected to the tibial component; and a proximal portion that extends between the medial and lateral condyles; wherein the proximal portion has a pair of parallel medial and lateral side walls and a top wall perpendicular to the pair of side walls in an anterior portion.
    • Claim:
      5. The knee prosthesis of claim 4 , wherein the proximal portion of the projection has a pair of curved medial and lateral side walls and a flat top wall extending between the pair of curved side walls in a posterior portion.
    • Claim:
      6. The knee prosthesis of claim 4 , wherein the pair of parallel medial and lateral side walls extend vertically and parallel to the axis in the anterior portion of the projection.
    • Claim:
      7. The knee prosthesis of claim 6 , wherein each of the medial and lateral condyles includes a vertically oriented interior wall facing toward the projection, the vertical interior walls being parallel to the pair of parallel medial and lateral side walls.
    • Claim:
      8. The knee prosthesis of claim 4 , wherein the posterior wall of the patella-femoral flange and the anterior wall of the projection are configured to engage in the extended position when the knee prosthesis is in zero degrees of knee flexion, wherein in the extended position the posterior wall and the anterior wall engage along an interface that slopes posteriorly in a direction extending from the distal portion to the proximal portion.
    • Claim:
      9. The knee prosthesis of claim 1 , wherein the knee prosthesis transitions from the more constrained, extended position to the less constrained, flexed position between 10° and 30° of knee flexion.
    • Claim:
      10. The knee prosthesis of claim 1 , wherein the projection is positioned slightly anteriorly of an anterior-posterior midpoint of the tibial component.
    • Claim:
      11. The knee prosthesis of claim 1 , wherein the projection has a maximum height such that a superior tip of the projection is disengaged from the femoral component in the extended position and the flexed position to facilitate rolling translation of the femoral component against the tibial component.
    • Claim:
      12. A knee prosthesis comprising: a femoral component including: a medial condyle; a lateral condyle; and a patella-femoral flange positioned between the medial and lateral condyles; wherein the medial condyle and the lateral condyle respectively define two planar femoral surfaces that form opposing sides of an intercondylar compartment; and a tibial component including: a medial surface sized to receive the medial condyle of the femoral component; a lateral surface sized to receive the lateral condyle of the femoral component; and a projection extending from between the medial and lateral surfaces into the intercondylar compartment, the projection including two planar tibial surfaces at an anterior end of the projection that are configured to flushly engage the two planar surfaces of the intercondylar compartment, respectively, in extension, and the two planar tibial surfaces transition to two curved surfaces at a posterior end of the projection joined by a planar and horizontal proximal surface; wherein the projection is positioned in an anterior-posterior direction on the tibial component anteriorly of an anterior-posterior midpoint of the tibial component so that the patella-femoral flange is configured to fully disengage from the femoral component in flexion.
    • Claim:
      13. The knee prosthesis of claim 12 , wherein the projection is positioned slightly anteriorly of the anterior-posterior midpoint of the tibial component.
    • Claim:
      14. The knee prosthesis of claim 13 , wherein the projection has a height such that a superior tip of the projection is disengaged from the femoral component in extension and flexion to facilitate rolling translation of the femoral component against the tibial component.
    • Claim:
      15. The knee prosthesis of claim 12 , wherein: the two planar femoral surfaces include two parallel condylar surfaces; and the two planar tibial surfaces include two parallel projection surfaces configured to engage the two parallel condylar surfaces; wherein the two parallel condylar surfaces and the two parallel projection surfaces engage in extension and are parallel to a longitudinal axis of the knee prosthesis to prevent rotation and lateral movement of the femoral component relative to the tibial component.
    • Claim:
      16. The knee prosthesis of claim 12 , wherein: the two planar femoral surfaces further comprise a posterior surface connecting the two parallel condylar surfaces; and the two planar tibial surfaces further comprise an anterior surface connecting the two parallel projection surfaces; wherein the posterior surface engages the anterior surface in extension to prevent posterior movement of the femoral component relative to the tibial component.
    • Claim:
      17. A knee prosthesis including an axis that is medially offset from a center of the knee prosthesis, the knee prosthesis comprising: a femoral component including: a medial condyle including a medial wall extending parallel to the axis; a lateral condyle including a lateral wall extending parallel to the medial wall; and a patella-femoral flange connecting the medial and lateral condyles, the patella-femoral flange including a posterior wall connecting the medial and lateral walls; and a tibial component including: a medial surface sized to receive the medial condyle of the femoral component; a lateral surface sized to receive the lateral condyle of the femoral component; and a projection extending from between the medial and lateral surfaces anteriorly of an anterior-posterior midpoint of the tibial component into a space between the medial and lateral condyles, the projection including: a medial surface configured to flushly engage the medial wall in extension; and a lateral surface configured to flushly engage the lateral wall in extension; wherein the projection: decreases in height from an anterior end to a posterior end; decreases in width from the anterior end to the posterior end; the medial and lateral surfaces are planar at the anterior end; and the medial and lateral surfaces are curved at the posterior end.
    • Claim:
      18. The knee prosthesis of claim 17 , wherein the projection has a maximum height such that a superior surface of the projection is disengaged from the femoral component in extension and flexion to facilitate rolling translation of the femoral component against the tibial component.
    • Claim:
      19. The knee prosthesis of claim 17 , wherein the projection comprises: an anterior portion having a cross-sectional profile wherein the medial and lateral surfaces are vertical and joined by a planar and horizontal proximal surface; and a posterior portion having a cross-sectional profile wherein the medial and lateral surfaces are curved and joined by the planar and horizontal proximal surface.
    • Claim:
      20. The knee prosthesis of claim 17 , wherein: the projection includes an anterior surface configured to engage with the posterior wall in extension.
    • Patent References Cited:
      3798679 March 1974 Ewald
      3816855 June 1974 Saleh
      4112522 September 1978 Dadurian et al.
      4209861 July 1980 Walker et al.
      4215439 August 1980 Gold
      5147405 September 1992 Van Zile
      5219362 June 1993 Tuke et al.
      5236461 August 1993 Forte
      5282870 February 1994 Moser et al.
      5330534 July 1994 Herrington et al.
      5358527 October 1994 Forte
      5370699 December 1994 Hood et al.
      5413604 May 1995 Hodge
      5549686 August 1996 Johnson et al.
      5728162 March 1998 Eckhoff
      6013103 January 2000 Kaufman et al.
      6056779 May 2000 Noyer et al.
      6342075 January 2002 MacArthur
      6406497 June 2002 Takei et al.
      6475241 November 2002 Pappas
      6491726 December 2002 Pappas
      6558426 May 2003 Masini
      6660039 December 2003 Evans et al.
      6699291 March 2004 Augoyard et al.
      6764516 July 2004 Pappas
      6783550 August 2004 MacArthur
      6797005 September 2004 Pappas
      7081137 July 2006 Servidio
      7160330 January 2007 Axelson, Jr. et al.
      7309362 December 2007 Yasuda et al.
      7326252 February 2008 Otto et al.
      7351263 April 2008 Afriat
      7413577 August 2008 Servidio
      7615054 November 2009 Bonutti
      7635390 December 2009 Bonutti
      8192498 June 2012 Wagner et al.
      8236061 August 2012 Heldreth et al.
      8491661 July 2013 Mouillet et al.
      8932365 January 2015 Parisi et al.
      9132014 September 2015 Sanford et al.
      9615929 April 2017 Sanford
      9662217 May 2017 Heggendorn et al.
      9861484 January 2018 Sanford et al.
      10076420 September 2018 Sanford
      2003/0009232 January 2003 Metzger et al.
      2004/0143339 July 2004 Stuart, Jr. et al.
      2005/0209701 September 2005 Suguro et al.
      2007/0135925 June 2007 Walker
      2007/0135926 June 2007 Walker
      2007/0173946 July 2007 Bonutti
      2007/0233269 October 2007 Steines et al.
      2008/0097615 April 2008 Lipman et al.
      2008/0119940 May 2008 Otto et al.
      2009/0204221 August 2009 Walker
      2009/0210066 August 2009 Jasty
      2009/0222103 September 2009 Fitz et al.
      2009/0306786 December 2009 Samuelson
      2009/0319047 December 2009 Walker
      2009/0319049 December 2009 Shah et al.
      2009/0326665 December 2009 Wyss et al.
      2010/0016977 January 2010 Masini
      2010/0016979 January 2010 Wyss et al.
      2010/0036499 February 2010 Pinskerova
      2010/0042224 February 2010 Otto et al.
      2010/0161067 June 2010 Saleh et al.
      2010/0249940 September 2010 Sanford
      2010/0286788 November 2010 Komistek
      2010/0305708 December 2010 Lang
      2010/0329530 December 2010 Lang et al.
      2011/0144760 June 2011 Wong et al.
      2012/0089234 April 2012 Mouillet et al.
      2012/0095563 April 2012 Sanford et al.
      2012/0095564 April 2012 Mihalko et al.
      2012/0179265 July 2012 Wyss et al.
      2012/0323337 December 2012 Parisi et al.
      2013/0006373 January 2013 Wyss et al.
      2013/0190884 July 2013 Hashida
      2013/0197653 August 2013 Hawkins et al.
      2013/0204380 August 2013 Mouillet et al.
      2014/0243989 August 2014 Nabeshima et al.
      2015/0025644 January 2015 Heggendorn et al.
      2015/0134067 May 2015 Qu et al.
      2015/0164646 June 2015 Muratoglu
      2015/0305873 October 2015 Sanford et al.
      2017/0165079 June 2017 Sanford
      0123016 October 1984
      1121074 July 2008
      1555962 February 2011
      2324799 May 2011
      2335654 June 2011
      2004166802 June 2004
      WO-0023011 April 2000
      WO-2005051240 June 2005
      WO-2006058057 June 2006
      WO-2007109641 September 2007
      WO-2011018441 February 2011
      WO-2011072235 June 2011
      WO-2012031774 March 2012
      WO-2012112698 August 2012
      WO-2013007747 January 2013


























































    • Other References:
      “U.S. Appl. No. 15/442,925, Notice of Allowance dated Jun. 21, 2018”, 7 pgs. cited by applicant
      “U.S. Appl. No. 14/509,753, filed Sep. 7, 2016 to Final Office Action dated Jul. 7, 2016”, 9 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, Examiner Interview Summary dated Apr. 8, 2013”, 3 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, Final Office Action dated Sep. 25, 2013”, 9 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, Non Final Office Action dated Apr. 9, 2015”, 8 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, Non Final Office Action dated May 18, 2016”, 13 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, Non Final Office Action dated Oct. 26, 2011”, 8 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, Notice of Allowance dated Dec. 5, 2016”, 7 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, filed Jan. 20, 2016 to Non-Final Office Action dated Oct. 20, 2015”, 16 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, filed Jan. 26, 2012 to Non Final Office Action dated Oct. 26, 2011”, 12 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, filed Feb. 25, 2014 to Final Office Action dated Sep. 25, 2013”, 15 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, filed May 11, 2012 to Non Final Office Action dated Oct. 26, 2011”, 3 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, filed Jun. 16, 2015 to Non-Final Office Action dated Apr. 9, 2015”, 17 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, filed Aug. 18, 2016 to Non Final Office Action dated May 18, 2016”, 15 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, filed Aug. 26, 2011 to Restriction Requirement dated Jul. 7, 2011”, 2 pgs. cited by applicant
      “U.S. Appl. No. 12/692,371, Restriction Requirement dated Jul. 7, 2011”, 6 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, Advisory Action dated Apr. 1, 2015”, 3 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, Final Office Action dated Jan. 27, 2015”, 12 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, Final Office Action dated Apr. 9, 2013”, 8 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, Non Final Office Action dated May. 28, 2014”, 15 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, Non Final Office Action dated Oct. 18, 2012”, 12 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, Notice of Allowance dated May 1, 2015”, 5 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, filed Feb. 19, 2013 to Non Final Office Action dated Oct. 18, 2012”, 16 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, filed Mar. 26, 2015 to Final Office Action dated Jan. 27, 2015”, 16 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, filed Apr. 21, 2015 to Advisory Action dated Apr. 1, 2015”, 16 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, filed Jul. 9, 2013 to Final Office Action dated Apr. 9, 2013”, 13 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, filed Oct. 1, 2012 to Restriction Requirement dated Aug. 29, 2012”, 6 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, filed Nov. 24, 2014 to Non Final Office Action dated May 28, 2014”, 15 pgs. cited by applicant
      “U.S. Appl. No. 13/086,104, Restriction Requirement dated Aug. 29, 2012”, 6 pgs. cited by applicant
      “U.S. Appl. No. 14/131,986, Preliminary Amendment filed Jan 10, 2014”, 3 pgs. cited by applicant
      “U.S. Appl. No. 14/509,753, Final Office Action dated Jul. 7, 2016”, 5 pgs. cited by applicant
      “U.S. Appl. No. 14/509,753, Non Final Office Action dated Jan. 25, 2016”, 9 pgs. cited by applicant
      “U.S. Appl. No. 14/509,753, Notice of Allowance dated Feb. 8, 2017”, 7 pgs. cited by applicant
      “U.S. Appl. No. 14/509,753, Notice of Allowance dated Sep. 19, 2016”, 8 pgs. cited by applicant
      “U.S. Appl. No. 14/509,753, Preliminary Amendment filed Oct. 8, 2014”, 3 pgs. cited by applicant
      “U.S. Appl. No. 14/509,753, Response filed May 4, 2016 to Non Final Office Action dated Jan. 25, 2016”, 14 pgs. cited by applicant
      “U.S. Appl. No. 14/793,152, Non Final Office Action dated May. 19, 2017”, 14 pgs. cited by applicant
      “U.S. Appl. No. 14/793,152, Notice of Allowance dated Sep. 19, 2017”, 10 pgs. cited by applicant
      “U.S. Appl. No. 14/793,152, Preliminary Amendment filed Jul. 7, 2015”, 3 pgs. cited by applicant
      “U.S. Appl. No. 14/793,152, filed Aug. 18, 2017 to Non Final Office Action dated May 19, 2017”, 14 pgs. cited by applicant
      “U.S. Appl. No. 14/793,152, Supplemental Preliminary Amendment filed Jul. 9, 2015”, 8 pgs. cited by applicant
      “Application U.S. Appl. No. 14/826,807, Non Final Office Action dated Oct. 20, 2015”, 9 pgs. cited by applicant
      “U.S. Appl. No. 15/442,925, Non Final Office Action dated Nov. 13, 2017”, 13 pgs. cited by applicant
      “U.S. Appl. No. 15/442,925, Preliminary Amendment filed Mar. 3, 2017”, 8 pgs. cited by applicant
      “U.S. Appl. No. 15/442,925, filed Sep. 5, 2017 to Restriction Requirement dated Jul. 5, 2017”, 9 pgs. cited by applicant
      “U.S. Appl. No. 15/442,925, filed Feb. 12, 2018 to Non Final Office Action dated Nov. 13, 2017”, 18 pgs. cited by applicant
      “U.S. Appl. No. 15/442,925, Restriction Requirement dated Jul. 5, 2017”, 6 pgs. cited by applicant
      “U.S. Appl. No. 61/381,803, Application filed Sep. 10, 2010”, 23 pgs. cited by applicant
      “Bi-Cruciate Stabilized Knee System”, Design Rationale, Smith & Nephew Journal, (2006), 20 pgs. cited by applicant
      “Complete Knee Solution Surgical Technique for the CR-Flex Fixed Bearing Knee”, Zimmer Nexgen, (2003), 22 pgs. cited by applicant
      “International Application Serial No. PCT/EP2012/063575, Demand and Letter filed May 13, 2013”, 11 pgs. cited by applicant
      “International Application Serial No. PCT/EP2012/063575, International Preliminary Report on Patentability dated Dec. 2, 2013”, 9 pgs. cited by applicant
      “International Application Serial No. PCT/EP2012/063575, International Search Report dated Oct. 11, 2012”, 5 pgs. cited by applicant
      “International Application Serial No. PCT/EP2012/063575, Written Opinion dated Oct. 11, 2012”, 7 pgs. cited by applicant
      “International Application Serial No. PCT/US2010/021818, International Preliminary Report on Patentability dated Jul. 26, 2011”, 8 pgs. cited by applicant
      “International Application Serial No. PCT/US2010/021818, International Search Report dated Apr. 20, 2010”, 4 pgs. cited by applicant
      “International Application Serial No. PCT/US2010/021818, Written Opinion dated Apr. 20, 2010”, 8 pgs. cited by applicant
      “LPS Flex Fixed Bearing Knee”, Zimmer Surgical Technique, (2004, 2007), 12 pgs. cited by applicant
      Li, Guoan, et al., “Anterior Cruciate Ligament Deficiency Alters the in Vivo Motion of the Tibiofemoral Cartilage Contact Points in Both the Anteroposterior and Mediolateral Directions”, The Journal of Bone & Joint Surgery, (2006), 1826-1834. cited by applicant
    • Primary Examiner:
      Watkins, Marcia L
    • Attorney, Agent or Firm:
      Schwegman Lundberg & Woessner, P.A.
    • الرقم المعرف:
      edspgr.10667919